##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 87 Download : 73

##plugins.themes.academic_pro.article.main##

Abstract

Coronavirus disease (COVID – 19) was one of the most severe pandemics that the world has ever seen. The infection ranges from asymptomatic, mild to life threatening respiratory distress. It can affect almost every organ of the body, including the organ of vision. Ophthalmic manifestations may be present in the course of COVID-19 infection or they may develop later in rehabilitation period. The aim of the research is to facilitate the diagnostics and initiation of comprehensive therapy of pathological eye conditions of ocular surface and cornea that occur in coronavirus disease

Keywords

including one pandemics respiratory

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Abdullaev Shakhzodbek, Mamatkhujaeva Gulnara, & Abdullaev Aybek. (2022). Clinical manifest of post COVID-19 syndrome on ocular surface and cornea. Texas Journal of Medical Science, 10, 16–18. https://doi.org/10.62480/tjms.2022.vol10.pp16-18
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study Indian J Ophthalmol. 2020;68:1546–50
  2. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: A cross-sectional study Acta Ophthalmol. 2020;98:e951–9
  3. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease Br J Ophthalmol. 2020;104:748–51
  4. Nayak B, Poddar C, Panigrahi MK, Tripathy S, Mishra B. Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia Indian J Ophthalmol. 2020;68:1675–7
  5. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, et al Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) Can J Ophthalmol. 2020;55:e125–9
  6. Guo D, Xia J, Wang Y, Zhang X, Shen Y, Tong JP. Relapsing viral keratoconjunctivitis in COVID-19: A case report Virol J. 2020;17:1–7
  7. Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2 Am J Ophthalmol Case Rep. 2020;19:100735
  8. Danthuluri V, Grant MB. Update and recommendations for ocular manifestations of COVID-19 in adults and children: A narrative review Ophthalmol Ther. 2020;9:853–75
  9. Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, et al Ocular findings in COVID-19 patients: A review of direct manifestations and indirect effects on the eye? J Ophthalmol. 2020;2020:4827304 doi: 10.1155/2020/4827304
  10. Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report? Am J Ophthalmol Case Rep. 2020;20:100917 doi: 10.1016/j.ajoc.2020.100917
  11. Mangana CM, Kargacin AB, Barraquer RI. Episcleritis as an ocular manifestation in a patient with COVID-19 Acta Ophthalmol. 2020 doi: 10.1111/aos.14484
  12. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease Br J Ophthalmol. 2020;104:748–51